The large scale industrial manufacture of the nasal decongestant pseudoephedrine is typically carried out by the reductive amination of l-phenylacetylcarbinol (l-PAC), which in turn is produced via the biotransformation of benzaldehyde using yeast. In recent years there has been increasing legislative control of the supply of pseudoephedrine due to it being diverted for the clandestine production of methylamphetamine and there is some evidence that a number of clandestine drug laboratory chemists have considered the application of the l-PAC process to manufacture their own pseudoephedrine. This work examined the use of a number of substituted benzaldehydes for the manufacture of the corresponding substituted l-PAC analogue followed by reductive amination to the corresponding substituted pseudoephedrine/ephedrine analogues. These substituted pseudoephedrine/ephedrine analogues were either reduced or oxidised to determine the feasibility of producing the corresponding methylamphetamine or methcathinone analogues. As a result, the l-PAC process was identified as a viable route for synthesis of substituted methylamphetamines and methcathinones.
Introduction
The l-Phenylacetylcarbinol (l-PAC) process is a biotransformation process using the fungus yeast. The mechanism, which was initially investigated by Neuberg et al. 1,2 , involves glycolysis of glucose to produce pyruvic acid which is then decarboxylated by pyruvate decarboxylase to produce acetaldehyde. The resulting acetaldehyde then undergoes a condensation reaction with benzaldehyde to produce l-PAC [(R)-1-hydroxy-1-phenylpropan-2-one]. During this process, by-products are formed due to the action of alcohol dehydrogenase on benzaldehyde and l-PAC resulting in benzyl alcohol and (1R,2S)-1-phenylpropan-1,2-diol (PAC-diol) respectively. 3, 4 (Refer to Scheme 1)
The l-PAC process has previously been employed by the pharmaceutical industry due to the ease with which l-PAC can be chemically converted to pseudoephedrine/ephedrine. In recent years, a number of clandestine drug laboratories have been located which have exploited the commercial process for the production of pseudoephedrine/ephedrine for use in the manufacture of methylamphetamine 3 .
Global controls over the supply of pseudoephedrine as a potential illicit drug precursor has heightened the possibility that this process will gain increased importance in illicit drug production. This process has dual applicability in that the pseudoephedrine/ephedrine produced by this process can be employed for both methylamphetamine and methcathinone production. Scheme 1: Mechanism of the fermentation of benzaldehyde to produce l-PAC and various byproducts 3, 4 The work presented here aimed to investigate the l-PAC process as a viable manufacturing pathway to produce a variety of substituted methylamphetamines and methcathinones and hence identify the potential emerging precursor chemicals for substituted methylamphetamine and methcathinone analogues. 
Materials and Methods

Materials
Instrumentation
Gas Chromatography-Mass Spectrometry (GC-MS) analyses were performed on an Agilent HP-6890N Network GC System using an Agilent HP-5MS capillary column 
Bisulfite Adduct Purification prior to NMR Analysis
Whilst our intent was to only perform minimal purification in order to observe reaction marker by-products at each stage, the corresponding l-PAC products were purified prior to NMR analysis by the bisulfite adduct purification technique previously employed by Neuberg and Ohle 5 . Each crude sample was taken up in 10 mL diethyl ether and extracted with saturated sodium carbonate solution (2 x 5 mL) to remove excess benzoic acid. The diethyl ether layer was then washed with deionised water (2 x 5 mL), the aqueous extracts combined and further extracted with diethyl ether (2 x 5 mL). The diethyl ether extracts were then combined and 15 mL of a freshly made saturated sodium hydrosulfite solution was added. The solution was left to react for 60 mins, being shaken every few minutes. Any benzyl alcohol in the sample was then removed through extraction with diethyl ether (3 x 10 mL). To the retained aqueous layer, solid sodium bicarbonate was added until the evolution of carbon dioxide ceased. This aqueous layer was then extracted with diethyl ether (3 x 10 mL), dried over anhydrous sodium sulphate, filtered and evaporated on a rotary evaporator. A sample of each product was dissolved in chloroform and assessed for purity by GC-MS prior to NMR analysis.
Reductive Amination Procedure
Using quantities as outlined in Table 2 , ethanol and methylamine (40% in water) was added to each sample of crude l-PAC analogue and left to react at room temperature for 30 mins, to allow imine formation. The solution was cooled in an ice bath and reduced using sodium borohydride for 90 mins. The solution was then basified with a 10% sodium hydroxide solution (approximately 10 mL) and extracted with dichloromethane (3 x 10 mL). The combined extracts were dried over anhydrous sodium sulphate, filtered and evaporated. A sample of each product was dissolved in chloroform and analysed by GC-MS and GC-IRD.
Excess benzyl alcohol that had formed as a by-product was then removed through an acid-base extraction. The sample was acidified using 10 mL of 10% hydrochloric acid, shaken briefly and extracted with dichloromethane (3 x 10 mL) to remove the neutral components. The aqueous layer was then basified with a 10% solution of sodium hydroxide in water and extracted with dichloromethane (3 x 10 mL). The combined extracts were dried over anhydrous sodium sulphate, filtered and evaporated on a rotary evaporator. A sample of each product was collected, dissolved in chloroform and analysed by GC-MS and GC-IRD. Specific quantities of each reagent can be found in Table 2 . 
Reduction Procedure
To each of the pseudoephedrine/ephedrine analogues a mixture of iodine in hypophosphorous acid was added. Each solution was refluxed for 120 mins and allowed to cool to room temperature. Each solution was basified with a saturated sodium carbonate solution and extracted with chloroform (3 x 10 mL). The combined extracts were dried over anhydrous sodium sulphate, filtered and evaporated on a rotary evaporator. A sample of each product was dissolved in chloroform and analysed by GC-MS and GC-IRD. Specific quantities of each reagent can be found in Table 3 . Table 4 .
Methcathinone has a tendency to form a pyrazine dimer when in the free base form 6 .
For stability purposes the analogues were converted to the corresponding hydrochloride salt by the addition of hydrogen chloride gas to each of the substituted methcathinone samples in chilled isopropyl alcohol. Once the pH of the solution had reached pH 3 or lower, it was placed on a heater block and the solvent evaporated under a stream of nitrogen. 
Results and Discussion
The synthetic pathway employed to obtain the respective analogues is outlined in Scheme 2. Products formed during fermentation, reductive amination, reduction and oxidation of the various precursors are outlined in Tables 3, 4 , 5, and 6 respectively. 
Substituted Methylamphetamine
Scheme 2: The substituted benzaldehydes of interest investigated and the pathway followed.
Fermentation
Initially, a number of small scale fermentations were conducted to examine the l-PAC process parameters using benzaldehyde. The parameters of buffer, buffer volume, temperature and acetaldehyde addition were examined. It was found that a pH 5 0.1 M citrate buffer made from dissolving trisodium citrate and citric acid in deionised water gave a higher yield of l-PAC than when a deionised water buffer was employed. The buffer volumes were then altered to produce a benzaldehyde concentration of 12 g/L and 6 g/L with the 6 g/L fermentation broth found to produce the highest l-PAC yield. It was also found that heating the fermentation Table   5 . Note: Calculated percentage yields (calc'd % yield) were found by comparing the theoretical yield of each compound with the compound's actual yield (calculated using the crude product weight and the relative (area %) of the compound, reported during GC-MS analysis). Figure 1 for proton and carbon labels).
4-Methyl Analogue of l-PAC
To confirm the production of 4-methyl-PAC 22, the sample which was purified via the bisulfite adduct method was analysed by 1 Figure 2 for proton labels). A gCOSY (gradient correlation spectroscopy) spectrum was also obtained to confirm the assignment of each proton signal. The assignment of these compounds was therefore made using GC-MS and GC-IRD analysis.
4-Methylthio Analogue of l-PAC
Throughout the fermentations, full conversion of the substituted benzaldehydes to the corresponding l-PAC analogue proved difficult due to competing side reactions.
Unlike benzaldehyde, the substituted benzaldehydes all produced fermentation products with anywhere between 5-30% (GC-MS relative yield) substituted benzaldehyde. 
Shin and Rogers
Reductive Amination
The results of the reductive amination of each of the crude l-PAC analogue samples appear in Table 6 . In each reductive amination where the crude l-PAC analogue used contained substituted benzaldehyde, the corresponding N-methyl-benzylamine analogue was produced, formed through the amination of residual benzyl alcohol. The presence of N-methyl-benzylamine analogues can be used as an indicative marker that the product was synthesised from an initial substituted benzaldehyde fermentation followed by reductive amination.
According to the literature 8 the reductive amination of l-PAC should produce a conversion of 79% l-PAC to pseudoephedrine/ephedrine. Therefore, the reductive amination of l-PAC and the 4-fluoro and 4-methyl analogues of l-PAC appeared to be reasonable yielding reactions with conversion rates of 54%, 53% and 60%
respectively. Conversely, the reductive amination of the 3,4-methylenedioxy, 4-methoxy and 4-methylthio analogues of l-PAC were low yielding reactions (17%, 4.5% and 11% respectively).
Hypophosphorous Acid Reduction
The results of the hypophosphorous acid reduction of each of the crude pseudoephedrine/ephedrine analogue samples appear in Table 7 . Figure 4 for proton and carbon labels).
A proton signal for proton d was not observed in the 1 H NMR spectrum. It is proposed that this signal would have been present at approximately 9-10 ppm, however, this cannot be confirmed as this region was not viewable in the 1 H NMR spectrum.
The shifts assigned to the aromatic proton signals would also have been contributed to by the aromatic protons of N-methyl-4-fluorobenzylamine. It was extremely difficult to separate the signals of these two compounds due to their overlapping nature. Therefore δ in the region of 7.37-6.83 were attributed to the aromatic H's of both 4-fluoromethamphetamine and N-methyl-4-fluorobenzylamine.
Acid Dichromate Oxidation
The results of the acid dichromate oxidation of each of the crude pseudoephedrine/ephedrine analogue samples appear in Table 8 . 
